A STEM CELL PREPARATION METHOD FOR TREATING DIABETES MELLITUS
A STEM CELL PREPARATION METHOD FOR TREATING DIABETES Aspects of the present disclosure relate to a stem cell preparation method (100) which is used for the treatment of diabetes mellitus. Mesenchymal stem cells are special type of multifunctional stem cells which have the great potential for regenerative medicine and autoimmune disease. These stem cells are capable of getting to the site and then can directly differentiate into target cells. In this particular method (100) we have tried to extract the mesenchymal stem cells (102) from the umbilical cord tissue which are further used for the extraction (112) of the apoptotic bodies according to the procedure described. (FIG. 1 will be the reference figure) 100 inoculation of Mesenchymal stem cells 102 placing them in CO 2cultured incubator 104 obtaining fifth-generation Mesenchymal stem cells replacing medium with complete a-MEM 108 medium collecting cell culture supernatant 110 obtaining apoptotic bodies 112 dissolve human blood suspension ofthe Mesenchymal in a dispersion 116 medium adjusting final cell concentration 8 FIG. 1 Flow method of stem cell preparation for treating diabetes mellitus.
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Europäisches Patentamt - (2021) vom: 17. Juni Zur Gesamtaufnahme - year:2021 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
GUPTA AJAY KUMAR [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2021-06-17, Last update posted on www.tib.eu: 2023-12-11, Last updated: 2023-12-15 |
|---|
| Patentnummer: |
AU2021102200 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA011978473 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA011978473 | ||
| 003 | DE-627 | ||
| 005 | 20231215094311.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210729s2021 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA011978473 | ||
| 035 | |a (EPA)AU2021102200 | ||
| 035 | |a (EPA)76327697 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a GUPTA AJAY KUMAR |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a A STEM CELL PREPARATION METHOD FOR TREATING DIABETES MELLITUS |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2021-06-17, Last update posted on www.tib.eu: 2023-12-11, Last updated: 2023-12-15 | ||
| 520 | |a A STEM CELL PREPARATION METHOD FOR TREATING DIABETES Aspects of the present disclosure relate to a stem cell preparation method (100) which is used for the treatment of diabetes mellitus. Mesenchymal stem cells are special type of multifunctional stem cells which have the great potential for regenerative medicine and autoimmune disease. These stem cells are capable of getting to the site and then can directly differentiate into target cells. In this particular method (100) we have tried to extract the mesenchymal stem cells (102) from the umbilical cord tissue which are further used for the extraction (112) of the apoptotic bodies according to the procedure described. (FIG. 1 will be the reference figure) 100 inoculation of Mesenchymal stem cells 102 placing them in CO 2cultured incubator 104 obtaining fifth-generation Mesenchymal stem cells replacing medium with complete a-MEM 108 medium collecting cell culture supernatant 110 obtaining apoptotic bodies 112 dissolve human blood suspension ofthe Mesenchymal in a dispersion 116 medium adjusting final cell concentration 8 FIG. 1 Flow method of stem cell preparation for treating diabetes mellitus | ||
| 650 | 4 | |a bio | |
| 650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
| 650 | 4 | |a C12N: Microorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture media (microbiological testing media c12q0001000000) | |
| 650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
| 650 | 4 | |a che | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a TIWARI GAURAV |4 aut | |
| 700 | 0 | |a SINGH ANJU |4 aut | |
| 700 | 0 | |a TIWARI RUCHI |4 aut | |
| 700 | 0 | |a KATIYAR PRAVEEN |4 aut | |
| 700 | 0 | |a ANSARI VASEEM AHMAD |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2021) vom: 17. Juni |
| 773 | 1 | 8 | |g year:2021 |g day:17 |g month:06 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/76327697/publication/AU2021102200A1?q=AU2021102200 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 936 | u | w | |j 2021 |b 17 |c 06 |
| 951 | |a AR | ||
| 952 | |j 2021 |b 17 |c 06 | ||